Management of retinopathy of prematurity (ROP) in a Polish cohort of infants
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Management of retinopathy of prematurity (ROP) in a Polish cohort of infants
Authors
Keywords
-
Journal
Scientific Reports
Volume 11, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-02-25
DOI
10.1038/s41598-021-83985-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Describing Retinopathy of Prematurity: Current Limitations and New Challenges
- (2019) Alistair R. Fielder et al. OPHTHALMOLOGY
- Ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW): an open-label randomised controlled trial
- (2019) Andreas Stahl et al. LANCET
- Medical and developmental outcomes of bevacizumab versus laser for retinopathy of prematurity
- (2018) Kathleen A. Kennedy et al. JOURNAL OF AAPOS
- Behandelte Frühgeborenenretinopathie in Deutschland
- (2018) J. M. Walz et al. OPHTHALMOLOGE
- Follow-up to Age 4 Years of Treatment of Type 1 Retinopathy of Prematurity Intravitreal Bevacizumab Injection versus Laser: Fluorescein Angiographic Findings
- (2018) Domenico Lepore et al. OPHTHALMOLOGY
- Pathophysiology, screening and treatment of ROP: A multi-disciplinary perspective
- (2018) Tailoi Chan-Ling et al. PROGRESS IN RETINAL AND EYE RESEARCH
- Increase in treatment of severe retinopathy of prematurity following a new national guideline
- (2018) Kasia Trzcionkowska et al. ACTA OPHTHALMOLOGICA
- Incidence and Early Course of Retinopathy of Prematurity
- (2018) Graham E. Quinn et al. JAMA Ophthalmology
- Anti-Vascular Endothelial Growth Factor Therapy for Primary Treatment of Type 1 Retinopathy of Prematurity
- (2017) Deborah K. VanderVeen et al. OPHTHALMOLOGY
- THE CUTTING EDGE OF RETINOPATHY OF PREMATURITY CARE
- (2017) Yoshihiro Yonekawa et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- RETINAL VASCULAR DEVELOPMENT WITH 0.312 MG INTRAVITREAL BEVACIZUMAB TO TREAT SEVERE POSTERIOR RETINOPATHY OF PREMATURITY
- (2017) Birgit Lorenz et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Ranibizumab after laser photocoagulation failure in retinopathy of prematurity (ROP) treatment
- (2017) Anna Gotz-Więckowska et al. Scientific Reports
- Treatment trends for retinopathy of prematurity in the UK: active surveillance study of infants at risk
- (2017) Gillian G W Adams et al. BMJ Open
- The German ROP Registry: data from 90 infants treated for retinopathy of prematurity
- (2016) Johanna M. Walz et al. ACTA OPHTHALMOLOGICA
- Five years of treatment for retinopathy of prematurity in Sweden: results from SWEDROP, a national quality register
- (2016) Gerd Holmström et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Plus Disease in Retinopathy of Prematurity
- (2016) J. Peter Campbell et al. OPHTHALMOLOGY
- Concerns for Development After Bevacizumab Treatment of ROP
- (2016) G. E. Quinn et al. PEDIATRICS
- Neurodevelopmental Outcomes Following Bevacizumab Injections for Retinopathy of Prematurity
- (2016) J. Morin et al. PEDIATRICS
- Neurodevelopmental Outcomes in Infants with Retinopathy of Prematurity and Bevacizumab Treatment
- (2016) Reyin Lien et al. PLoS One
- Outcome and quality of screening in a nationwide survey on retinopathy of prematurity in The Netherlands
- (2014) A J van Sorge et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Refractive Outcomes Following Bevacizumab Monotherapy Compared With Conventional Laser Treatment
- (2014) Megan M. Geloneck et al. JAMA Ophthalmology
- Efficacy of Intravitreal Bevacizumab for Stage 3+ Retinopathy of Prematurity
- (2011) Helen A. Mintz-Hittner et al. NEW ENGLAND JOURNAL OF MEDICINE
- Treatment for Retinopathy of Prematurity in Denmark in a Ten-Year Period (1996 2005): Is the Incidence Increasing?
- (2008) C. Slidsborg et al. PEDIATRICS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started